ConsortiEX Blog

ConsortiEX and LedgerDomain Announce Strategic Partnership

MILWAUKEE, March 13, 2024 – ConsortiEX, an industry leader in compliance and patient-safety focused software and services for outsourcing and hospital pharmacies, is pleased to announce a new strategic partnership with LedgerDomain, a pioneering identity and secure messaging platform tailored for modern decentralized[...]

FDA Issues New Guidance on Suspect and Illegitimate Product

The FDA recently issued guidance on the definition of Suspect and Illegitimate Products, set forth in the Federal Food Drug and Cosmetic Act1. This guidance aims to assist trading partners in putting systems in place to identify and handle suspect and illegitimate products, meeting Drug Supply Chain Security Act[...]

ConsortiEX 2019, a Year in Review, See you at the ASHP Summer Meetings!

We want to thank all of those who were able to attend the 2019 ASHP Midyear Clinical Meeting. Being able to discuss your feedback and concerns, in person, is invaluable to us. 2019 was a very busy, yet exciting, year for the ConsortiEX family. We hope it was for you as well.

ConsortiEX's Assure-Trak® Features a Seamless Integration With ProntoPump

As the 2019 ASHP Midyear Clinical Meeting approaches, we want to take this time to announce the integration of our Assure-Trak® Compounding Management System’s Batch Compounding module with ProntoPump by ProntoPrep.

Announcing Verify on Receipt for DSCSA at ASHP Midyear

As we inch closer to the 2019 ASHP Midyear Clinical Meeting we want to give a glimpse of what we have in store, not only for ASHP, but for 2020 and beyond.

6 Best Practices to Help Achieve DSCSA Compliance

Many hospitals struggle to achieve optimal compliance with the Drug Supply Chain Security Act (DSCSA). The challenge to comply seems to come from an incomplete or inaccurate understanding of the regulations, which is understandable given the Act’s complexity. DSCSA was put in place to protect consumers from harmful[...]

FDA Guidance Under Current Good Manufacturing Practice

The FDA released a finalized questions and answers guidance on data integrity compliance. The FDA guidance adheres to requirements under current good manufacturing practice ( cGMP) for drugs and biologics.

In Recent Guidance, FDA aims for Patient Safety at 503B Facilities

The FDA has issued a guidance to 503B facilities regarding Current Good Manufacturing Practice (gCMB)

FDA Issues Guidance on Verification Systems

The FDA recently issued a draft guidance regarding verification* systems in accordance with the Drug Supply Chain Security Act (DSCSA).

ConsortiEX ASHP Midyear Recap, Prioritizing Patient Safety

We want to thank everybody who came to visit our booth at this year’s ASHP Midyear Clinical Meeting & Exhibition. We always appreciate the opportunity to show off our products to the people who need them most.

1 2


See all